Natural History of Pearson Syndrome
NCT02327364 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11
Last updated 2025-11-03
Summary
The purpose of this 3-year, multi-site, non-randomized, prospective, observational study is to characterize the natural history of Pearson Syndrome. The Syndrome is a rare mitochondrial disorder due to a large-scale mtDNA deletion. Children typically present in their 1st two years of life (most in infancy) with anemia and/or pancreatitis. Most individuals with Pearson Syndrome die in childhood. Those who survive evolve to Kearns-Sayre Syndrome/Chronic Progressive External Ophthalmoplegia (KSS/CPEO) although accurate survival estimates are not yet known.
Conditions
- Pearson Syndrome
Sponsors & Collaborators
-
National Institutes of Health (NIH)
collaborator NIH -
Sumit Parikh
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-03-31
- Primary Completion
- 2020-08-31
- Completion
- 2020-08-31
More Related Trials
-
Mucopolysaccharidosis Type II Natural History
NCT03529786 ·Status: COMPLETED
-
Natural History Clinical Study in Adult PKU
NCT04768348 ·Status: TERMINATED
-
Natural History Study to Characterise the Course of Disease Progression in Participants With Mucopolysaccharidosis Type IIIB
NCT02293408 ·Status: TERMINATED
-
Mitochondrial Dysfunction in Phelan-McDermid Syndrome
NCT02000167 ·Status: COMPLETED
-
Natural History of Netherton Syndrome
NCT05902663 ·Status: TERMINATED
-
Simple Breath Test to Examine Phenylalanine Metabolism
NCT02009904 ·Status: COMPLETED
-
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
NCT00076102 ·Status: COMPLETED ·Phase: PHASE2
-
Natural History Study of ENPP1 Deficiency and the Early-onset Form of ABCC6 Deficiency
NCT05050669 ·Status: COMPLETED
-
An Open-Label Study of Oral NNZ-2591 in Phelan-McDermid Syndrome (PMS-001)
NCT05025241 ·Status: COMPLETED ·Phase: PHASE2
-
Betaine and Peroxisome Biogenesis Disorders
NCT01838941 ·Status: COMPLETED ·Phase: PHASE3
-
Pyruvate Kinase Deficiency Natural History Study
NCT02053480 ·Status: COMPLETED
-
A Study to Assess the Safety and Pharmacokinetics of Multiple Ascending Subcutaneous Doses of DS-2325a in Healthy Subjects
NCT05583669 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety and Pharmacokinetics of Single Ascending Subcutaneous and Intravenous Doses of DS-2325a in Healthy Subjects
NCT05388903 ·Status: COMPLETED ·Phase: PHASE1
-
Review of Charts From Amish/Mennonite Variant PA Patients
NCT03159026 ·Status: COMPLETED
-
Study to Evaluate the Safety and Efficacy of Pegvaliase in Adolescents (Ages 12-17) With Phenylketonuria
NCT05270837 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Microcephaly, Fanconi Anemia and Praxial Disorders
NCT04656171 ·Status: WITHDRAWN ·Phase: NA
-
Longitudinal Study of Neurologic, Cognitive, and Radiologic Outcomes of PHACE Syndrome
NCT01018082 ·Status: COMPLETED
-
Oral Pyridoxal 5'-Phosphate for the Treatment of Patients With PNPO Deficiency
NCT04706013 ·Status: RECRUITING ·Phase: PHASE3
-
A Study to Evaluate the Effects of Pharmacological Chaperones in Cells From Patients With Pompe Disease
NCT00515398 ·Status: COMPLETED
-
A Natural History of Late Onset Tay-Sachs Disease
NCT02851862 ·Status: COMPLETED
-
Gene Therapy Clinical Study in Adult PKU
NCT03952156 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Angelman Syndrome Natural History Study-FAST UK
NCT05100810 ·Status: RECRUITING
-
Nutrition Status of Adults With PKU Before and During Treatment With Pegvaliase
NCT03856203 ·Status: COMPLETED
-
An Open-Label Study to Assess the Safety & Efficacy of Leniolisib in Japanese Patients With APDS
NCT06249997 ·Status: RECRUITING ·Phase: PHASE3
-
"The MaP Study": Mapping the Patient Journey in MMA and PA
NCT03484767 ·Status: COMPLETED